Cargando…
A novel CX3CR1 inhibitor AZD8797 facilitates early recovery of rat acute spinal cord injury by inhibiting inflammation and apoptosis
The present study aimed to evaluate the effect of the CX3CR1 inhibitor AZD8797 in early recovery after acute SCI and elucidate its potential mechanism in blocking inflammation and apoptosis. Adult rats were sacrificed after 3, 7, 10, or 14 days of SCI. The injured spinal tissues were collected for a...
Autores principales: | Chen, Guozhao, Zhou, Zhiping, Sha, Weiping, Wang, Liming, Yan, Fei, Yang, Xiaomei, Qin, Xia, Wu, Muyao, Li, Di, Tian, Shoujin, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138267/ https://www.ncbi.nlm.nih.gov/pubmed/32323731 http://dx.doi.org/10.3892/ijmm.2020.4509 |
Ejemplares similares
-
AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor
por: Cederblad, Linda, et al.
Publicado: (2016) -
Chronic Stress and Gonadectomy Affect the Expression of Cx37, Cx40 and Cx43 in the Spinal Cord
por: Jurić, Marija, et al.
Publicado: (2021) -
Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
por: Zhang, Jingjing, et al.
Publicado: (2018) -
Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
por: Bian, Chao, et al.
Publicado: (2015) -
Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents
por: Poniatowski, Łukasz A., et al.
Publicado: (2016)